Mouse study could provide foundation for future human therapeutics
Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig’s disease, according to a new study out of Case Western Reserve University School of Medicine. Researchers found high levels of the protein—called mitofusion 2 or Mfn2—prevented nerve degeneration, muscle atrophy, and paralysis in a mouse model of the disease. Since Mfn2 is often depleted during Lou Gehrig’s, the new study suggests supplementing it could be a novel therapeutic approach for the disease.
Lou Gehrig’s disease, or amyloid lateral sclerosis (ALS), is a progressive disorder that devastates motor nerve cells. People with ALS slowly lose the ability to control muscle movement, and are ultimately unable to speak, eat, move, or breathe. The cellular mechanisms behind ALS are also found in certain types of dementia. For the estimated 15,000 Americans living with ALS, the findings offer new hope for ways to delay symptoms.
“We found a way to alleviate age and ALS-related muscular atrophy in our mouse models,” said Xinglong Wang, PhD, associate professor of pathology at Case Western Reserve University School of Medicine. “Amazingly, we could delay ALS symptom onset by 67 days.”
Wang led the study, recently published in Cell Metabolism, in which researchers successfully staved off muscle atrophy and paralysis simply by increasing Mfn2 levels in mouse spinal cords.
Wang and colleagues tested the most widely used ALS mouse model. They genetically engineered the diseased mice to have increased Mfn2 levels—but only in nerve cells that extend from the spinal cord and connect to muscle fibers. In late stages of the disease, mice with high Mfn2 levels in these nerves were a healthy weight, and did not have any of the muscle atrophy, gait abnormalities, or reduced grip strength that mice in control groups developed. Even mice who underwent heavy sciatic nerve damage benefited from elevated Mfn2 levels.
Said Wang, “Upregulation of Mfn2 specifically in nerve cells is sufficient to abolish skeletal muscle loss in ALS and aged mice, despite ALS-causing protein being found in all organs and tissues.”
By studying nerve cells collected from the mice, Wang’s team uncovered how Mfn2 offers its protective effects. The researchers found Mfn2 coexists with nutrients in cell structures called mitochondria. Their experiments showed mitochondria travel along nerve cell extensions—axons—and deliver the nutrients to the point where nerve cells and muscle fibers meet. This preserves sensitive connections—synapses—between nerve and muscle cells and prevents muscle atrophy. “We found mitochondria function as miniature ‘trucks’ to transport protein along axons to prevent synaptic degeneration,” explained Wang.
Cellular transport is not typically in the job description for mitochondria. The ancient cellular structures are well-known to be “powerhouses of the cell”—producing energy that keeps cells running. According to Wang, “this is a novel, previously unrecognized role for mitochondria.”
Specifically, Wang’s team found mitochondria use Mfn2 on their surfaces to carry a nutrient called calpstatin. Calpstatin inhibits harmful enzymes that break down nerves and muscle fibers. With the help of Mfn2, mitochondria carry calpstatin along nerve cells axons to meet muscle cells. There, calpstatin prevents enzymes from destroying delicate synapse connections. But without Mfn2, mitochondria can’t carry the nutrient.
According to Wang, the findings have broad implications. “Mfn2 deficiency or mutations are commonly observed in patients with ALS, peripheral neuropathy, Alzheimer’s disease, and other neurodegenerative diseases in which synaptic loss has long been recognized as a prominent early feature,” he says. “Supplementing Mfn2 may be a common and effective therapeutic approach to treat a wide range of diseases including but not limited muscular disorders, patients with nerve injury and various major neurodegenerative diseases associated with synaptic loss.”
The Latest on: Lou Gehrig’s Disease
via Google News
The Latest on: Lou Gehrig’s Disease
- Lower Merion Police Officer Passes After ALS Fight At 49 on February 19, 2019 at 6:17 am
from complications from Amyotrophic Lateral Sclerosis more commonly known as ALS or Lou Gehrig's Disease He was 49. The beloved son of Armand and Joan Plisinski Temoyan, Gary was born on December ... […]
- Ben-Gurion University Introduces Novel AI Platform for Monitoring and Predicting ALS Progression on February 19, 2019 at 3:00 am
The technology, developed by Prof. Boaz Lerner of the Department of Industrial Engineering and Management at BGU, will initially focus on amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig's ... […]
- Dear Dr. Roach: How do diseases get their names? on February 19, 2019 at 2:00 am
Dear Dr. Roach: How does a medical condition get named? Once named, can the name be changed (for example, Lou Gehrig's disease, ALS)? I have a condition called hemiplegic migraines. It is rare and ... […]
- The Alumni Association’s 50th Buckeye Smart Series highlights ALS researchers at Ohio State and the search for the cure on February 18, 2019 at 10:35 pm
The luncheon, hosted by Dr. Stephen Kolb, will highlight the efforts of Ohio State researchers and clinicians who strive to find a cure for amyotrophic lateral sclerosis, also known as ALS or Lou Gehr... […]
- Lou Gehrig’s cap to sell for $200,000 on February 18, 2019 at 9:31 pm
Gehrig retired in 1939 because amyotrophic lateral sclerosis (ALS), later called Lou Gehrig’s disease. He was inducted into the Hall of Fame the same year and died in 1941. Steigler originally inherit... […]
- Former Yank Gehrig cap could sell for $200K at auction on February 18, 2019 at 8:03 pm
Gehrig retired in 1939 because amyotrophic lateral sclerosis (ALS), later called Lou Gehrig's disease. He was inducted into the Hall of Fame the same year and died in 1941. Steigler originally inherit... […]
- Ben-Gurion University unveils AI platform for predicting ALS progression on February 18, 2019 at 8:02 pm
such as Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s Disease. The platform analyzes demographic and clinical data of ALS patients using machine learning and data mining algorithms t... […]
- Lower Merion Police Officer succumbs to ALS. Lou Gehrig’s Disease on February 17, 2019 at 8:00 pm
Ardmore, Lower Merion Township, PA — Officer Gary Temoyan passed away yesterday. Temoyan was a member of the Lower Merion Police Department, and a notice of his death was posted by both the Lower Meri... […]
- ALS walk at Miromar Outlets raises awareness for disease on February 15, 2019 at 8:59 pm
ALS (amyotrophic lateral sclerosis) Lou Gehrig’s disease is incurable. It’s a disease percussionist Trimble McCullough lives with every day. McCullough hopes Southwest Florida can help find a cure soo... […]
via Bing News